ERBB2 and Familial prostate cancer: Although FLG and VCAN are less well explored in HER2+ BC, FLG mutations have been associated with higher tumor mutation load and immunogenicity in gastric cancer[36], while VCAN alterations have been linked to prostate cancer progression and docetaxel resistance[37,38].